Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Insulins

Journal articles and book chapters

08-13-2018 | Insulin glargine | Article

More similarities than differences testing insulin glargine 300 units/mL versus insulin degludec 100 units/mL in insulin-naive type 2 diabetes: The randomized head-to-head BRIGHT trial

Rosenstock J et al. Diabetes Care 2018: dc180559. doi: 10.2337/dc18-0559

08-02-2018 | Insulin pumps | Article

Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey

Taleb N et al. Diabetes Res Clin Prac 2018. doi: 10.1016/j.diabres.2018.07.035

07-30-2018 | Medications | Article

Choice of treatment regimen as add-on to insulin in Japanese patients with type 2 diabetes mellitus: Physicians’ perspective in a real-world setting, insight from a web survey

Imai K, Murayama H, Hirose T. Diabetes Ther 2018. doi: 10.1007/s13300-018-0476-3

07-20-2018 | Insulin pumps | Article

Optimizing a hybrid closed loop system in type 1 diabetes: A case report

The authors present the optimization of a hybrid closed-loop insulin pump system in an 11-year-old female with 7 years of type 1 diabetes.

Petrovski G et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0473-6

07-19-2018 | Dapagliflozin | Article

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 24-week results from a randomized controlled trial

Methieu C et al. Diabetes Care 2018: dc180623. doi: 10.2337/dc18-0623

07-16-2018 | Ipragliflozin | Article

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): A 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study

Ishihara H et al. Diabetol Int 2018. doi: 10.1007/s13340-018-0359-x

07-03-2018 | Insulin glargine | Article

Switching from pre-mixed insulin to regimens with insulin glargine in type 2 diabetes: A prospective, observational study of data from Adriatic countries

Kelishadi R et al. Diabetol Metab Syndr 2018; 10: 52. doi: 10.1186/s13098-018-0352-3

07-03-2018 | Hypoglycemia | Article

Association of initiation of basal insulin analogs vs neutral protamine Hagedorn insulin with hypoglycemia-related emergency department visits or hospital admissions and with glycemic control in patients with type 2 diabetes

Lipska KJ et al. JAMA 2018; 320: 53–62. doi: 10.1001/jama.2018.7993

06-30-2018 | Insulin NPH | Article

Glycemic control in hospitalized patients with diabetes receiving corticosteroids using a neutral protamine Hagedorn insulin protocol: A randomized clinical trial

Khowaja A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0468-3

06-30-2018 | Metformin | Review | Article

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy

van Stee MF, de Graaf AA, Groen AK. Cardiovasc Diabetol 2018; 17: 94. doi: 10.1186/s12933-018-0738-4

06-27-2018 | Hyperglycemia | Article

Contribution of BHG and PPHG to overall hyperglycemia in T2DM patients treated with LM25 and LM50: Post hoc analysis of a randomized crossover trial

Li W et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0462-9

06-26-2018 | Devices and technology | Review | Article

Technology in the management of type 1 diabetes mellitus: Current status and future prospects

Tauschmann M Hovorka R. Nat Rev Rheumatol 2018. doi: 10.1038/s41574-018-0044-y

06-25-2018 | Cardiovascular disorders | Review | Article

Shared genetic contribution of type 2 diabetes and cardiovascular disease: Implications for prognosis and treatment

Strawbridge RJ, van Zuydam NR. Curr Diab Rep 2018; 18: 59. doi: 10.1007/s11892-018-1021-5

06-25-2018 | Type 2 diabetes | Article

Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test

The RISE Consortium. Diabetes Care 2018. doi: 10.2337/dc18-0243

06-25-2018 | Gestational diabetes | Article

Polyphenol-rich foods and risk of gestational diabetes: A systematic review and meta-analysis

Pham NM, Do VV, Lee AH. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0218-7

06-25-2018 | Type 2 diabetes | Article

Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp

The RISE Consortium. Diabetes Care 2018. doi: 10.2337/dc18-0244

06-25-2018 | Type 2 diabetes | Article

Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes

The RISE Consortium. Diabetes Care 2018. doi: 10.2337/dc18-0787

06-24-2018 | Sotagliflozin | Article

Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: The North American inTandem1 study

Buse JB et al. Diabetes Care 2018. doi: 10.2337/dc18-0343

06-24-2018 | Drug-induced diabetes | Article

Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors

Stamatouli AM et al. Diabetes 2018. doi: 10.2337/dbi18-0002

06-23-2018 | Sitagliptin | Article

Efficacy and safety of sitagliptin in Hispanic/Latino patients with type 2 diabetes: A pooled analysis from ten randomized, placebo-controlled phase 3 clinical trials

Raji A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0461-x

Next Previous
Image Credits